- Home
- PHI vs BRKR Comparison
PHI vs BRKR Comparison
Compare PHI & BRKR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | PHI | BRKR |
|---|---|---|
| Founded | 1928 | 1960 |
| Country | Philippines | United States |
| Employees | N/A | N/A |
| Industry | Telecommunications Equipment | Biotechnology: Laboratory Analytical Instruments |
| Sector | Telecommunications | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.2B | 5.5B |
| IPO Year | N/A | 2000 |
Fundamental Metrics
Financial Performance| Metric | PHI | BRKR |
|---|---|---|
| Price | $22.57 | $36.74 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 1 | 13 |
| Target Price | N/A | ★ $49.54 |
| AVG Volume (30 Days) | 54.9K | ★ 2.3M |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | ★ 5.32% | 0.52% |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $1,895,600,000.00 |
| Revenue This Year | $4.43 | $5.75 |
| Revenue Next Year | $2.40 | $3.99 |
| P/E Ratio | $10.44 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $18.61 | $28.53 |
| 52 Week High | $25.12 | $56.22 |
Technical Indicators
Market Signals| Indicator | PHI | BRKR |
|---|---|---|
| Relative Strength Index (RSI) | 35.72 | 32.91 |
| Support Level | $22.15 | $35.41 |
| Resistance Level | $23.53 | $37.64 |
| Average True Range (ATR) | 0.43 | 1.63 |
| MACD | -0.24 | 0.09 |
| Stochastic Oscillator | 3.67 | 3.81 |
Price Performance
Historical ComparisonAbout PHI PLDT Inc. Sponsored ADR
PLDT Inc is the telecommunications carrier in the Philippines. The company's business activities include three business units: Wireless, Fixed Line and Others. The wireless segment consists of mobile telecommunications services provided by Smart and DMPI, and Fixed-line telecommunications services mainly provided by PLDT. It also provides fixed-line services through PLDT's subsidiaries.
About BRKR Bruker Corporation
Bruker Corp manufactures scientific instruments and diagnostic tests for customers in the life sciences, applied markets, pharmaceutical, and biotechnology industries. The company operates in segments, namely, Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI Nano, and Supercon Technologies (BEST). The company generates maximum revenue from the BSI CALID segment. Geographically, it derives the maximum of its revenue from United States.